MV Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Buy
157
+83
+112% +$5.53K ﹤0.01% 530
2026
Q1
$4.65K Buy
74
+6
+9% +$418 ﹤0.01% 637
2025
Q4
$4.51K Sell
68
-44
-39% -$2.85K ﹤0.01% 620
2025
Q3
$7.54K Sell
112
-36
-24% -$2.85K ﹤0.01% 559
2025
Q2
$12.9K Buy
148
+17
+13% +$1.33K ﹤0.01% 493
2025
Q1
$8.95K Sell
131
-58
-31% -$4.73K ﹤0.01% 535
2024
Q4
$14.7K Buy
189
+49
+35% +$3.63K ﹤0.01% 471
2024
Q3
$9.39K Sell
140
-136
-49% -$11.2K ﹤0.01% 541
2024
Q2
$31.3K Sell
276
-5
-2% -$632 ﹤0.01% 348
2024
Q1
$39K Buy
281
+4
+1% +$503 ﹤0.01% 322
2023
Q4
$34.4K Buy
277
+138
+99% +$14.1K ﹤0.01% 341
2023
Q3
$13K Sell
139
-84
-38% -$9.47K ﹤0.01% 461
2023
Q2
$28.7K Buy
223
+20
+10% +$2.42K ﹤0.01% 361
2023
Q1
$23.6K Buy
203
+33
+19% +$3.69K ﹤0.01% 377
2022
Q4
$19.3K Buy
170
+23
+16% +$2.52K ﹤0.01% 351
2022
Q3
$12K Buy
147
+55
+60% +$4.66K ﹤0.01% 417
2022
Q2
$7K Sell
92
-144
-61% -$13.1K ﹤0.01% 499
2022
Q1
$30K Buy
236
+100
+74% +$10.9K ﹤0.01% 278
2021
Q4
$18K Buy
136
+16
+13% +$2.3K ﹤0.01% 340
2021
Q3
$16K Buy
120
+48
+67% +$6.05K ﹤0.01% 342
2021
Q2
$8K Buy
72
+60
+500% +$5.76K ﹤0.01% 406
2021
Q1
$1K Buy
+12
New +$1.13K ﹤0.01% 355

Other funds holding DXCM

MV Capital Management's DXCM Position: Q2 2026 in Review

MV Capital Management increased its DexCom (DXCM) stake by 112% in Q2 2026, buying an estimated $5.53K and bringing the position to 157 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

MV Capital Management first reported a position in DXCM in Q1 2021 and has held it in 22 quarters since. The position peaked at $39K in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • MV Capital Management held 157 shares of DexCom worth $10.6K as of Q2 2026.
  • MV Capital Management bought 83 DexCom shares in Q2 2026, an estimated $5.53K.
  • DexCom made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #530 holding.
  • MV Capital Management first reported a position in DexCom in Q1 2021 and has held it in 22 quarters since.
  • MV Capital Management's DexCom position peaked at $39K in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.